Loading
institutionsInstitution
Princess Máxima Center for Pediatric Oncology
The national children's cancer centre of the Netherlands, which concentrates all Dutch paediatric oncology care and research on one Utrecht campus.
Also called: Prinses Máxima CentrumMáxima
Overview
Opened in 2018, the Princess Máxima Center brought together paediatric oncology from the Dutch university hospitals into a single specialised hospital and research institute next to UMC Utrecht and the Wilhelmina Children's Hospital. Every child is offered whole-genome and transcriptome sequencing at diagnosis, and research groups led by figures such as Jarno Drost, Monique den Boer and Michel Zwaan develop tumour organoids, leukaemia genomics and early-phase drug trials through the ITCC European consortium. Alexander Eggermont serves as chief scientific officer. The centre treats leukaemias, brain tumours, neuroblastoma, sarcomas and renal tumours, offers CAR-T and transplantation, and runs one of Europe's largest paediatric cancer survivorship programmes.
Location
Utrecht, NL
Type
cancer center · Utrecht University
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#144 · 34 points (0 Newsweek + 0 NCI + 34 from 17 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-16.
Matched to Princess Máxima Center, including child institutions. 324 works · 6,345 citations · 85% open access · 12% clinical trials · 4% reviews.
Oncology works per year
672022
732023
822024
632025
392026
Most works
- Alexander M.M. Eggermont48 works
- Stefan Nierkens35 works
- Alwin D. R. Huitema33 works
- Friso Calkoen26 works
- Gertjan J.L. Kaspers26 works
- Jürgen Kuball19 works
- Jos H. Beijnen19 works
- Paolo A. Ascierto18 works
- Dirk Schadendorf18 works
- Georgina V. Long18 works
Most cited
- National paediatric oncology hospital
- Whole-genome sequencing for every child
- Paediatric organoids
- ITCC early-phase trials
- Survivorship (LATER)
Inge M. van der Sluis
Paediatric oncologist, Princess Máxima Center for Pediatric Oncology
Infant leukaemiaImmunotherapy in paediatric leukaemiaAsparaginase
Dutch paediatric oncologist who led the study showing that adding one course of blinatumomab to chemotherapy sharply improves survival for babies with KMT2A-rearranged leukaemia.
Rob Pieters
Paediatric oncologist and Chief Medical Officer, Princess Máxima Center for Pediatric Oncology
Infant leukaemiaAcute lymphoblastic leukaemiaPaediatric oncology organisation
Dutch paediatric oncologist who led the international Interfant trials for babies with leukaemia and helped create the Princess Máxima Center, which brought all Dutch childhood cancer care into one hospital.
Alexander Eggermont
Chief Scientific Officer, Princess Máxima Center; Professor, Utrecht; former EORTC President
MelanomaAdjuvant immunotherapySurgical oncology
Surgical oncologist who led the EORTC adjuvant ipilimumab and pembrolizumab trials in melanoma.
René Medema
Chief Scientific Officer and member of the Raad van Bestuur, Prinses Máxima Centrum voor kinderoncologie
Cancer cell biologyResearch leadershipPaediatric oncology research
Cancer biologist and former head of the Netherlands Cancer Institute who sits on the three-member executive board of the Princess Máxima Center as Chief Scientific Officer.
Similar pages
- InstitutionGreat Ormond Street Hospital for Children
Shares Innovative Therapies for Children with Cancer (ITCC), Neuroblastoma (paediatric), Rare and paediatric cancers without markets, CAR-T cell therapy.
- InstitutionSydney Children's Hospitals Network / Children's Cancer Institute
Shares RNA sequencing & expression profiling, Neuroblastoma (paediatric), Whole-exome & whole-genome sequencing, Sarcomas (soft tissue, bone, GIST).
- InstitutionChildren's Cancer Hospital Egypt 57357
Shares Neuroblastoma (paediatric), Sarcomas (soft tissue, bone, GIST), Glioma & glioblastoma, Acute lymphoblastic leukaemia.
- IdeaAn open organoid bank for cancers too rare to have models
Shares Patient-derived organoids, Neuroblastoma (paediatric), Rare and paediatric cancers without markets, Sarcomas (soft tissue, bone, GIST).
- IdeaEscrow a share of adult revenue until the paediatric study is done
Shares Neuroblastoma (paediatric), Rare and paediatric cancers without markets, Sarcomas (soft tissue, bone, GIST), Acute lymphoblastic leukaemia.
- InstitutionSIOP Europe (European Society for Paediatric Oncology)
Shares Innovative Therapies for Children with Cancer (ITCC), EORTC, Neuroblastoma (paediatric), Rare and paediatric cancers without markets.
- InstitutionACCELERATE
Shares Innovative Therapies for Children with Cancer (ITCC), Neuroblastoma (paediatric), Rare and paediatric cancers without markets, Acute lymphoblastic leukaemia.
- PersonCrystal L. Mackall
Shares Neuroblastoma (paediatric), CAR-T cell therapy, Sarcomas (soft tissue, bone, GIST), Glioma & glioblastoma.